Two Sigma Advisers’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-28,500
| Closed | -$934K | – | 2837 |
|
|
2022
Q2 | $934K | Buy |
28,500
+8,100
| +40% | +$256K | ﹤0.01% | 1632 |
|
|
2022
Q1 | $536K | Sell |
20,400
-25,700
| -56% | -$627K | ﹤0.01% | 1956 |
|
|
2021
Q4 | $1.09M | Sell |
46,100
-12,900
| -22% | -$318K | ﹤0.01% | 1521 |
|
|
2021
Q3 | $1.48M | Buy |
59,000
+13,300
| +29% | +$339K | ﹤0.01% | 1417 |
|
|
2021
Q2 | $1.19M | Buy |
45,700
+9,700
| +27% | +$264K | ﹤0.01% | 1554 |
|
|
2021
Q1 | $922K | Sell |
36,000
-3,100
| -8% | -$79.5K | ﹤0.01% | 1700 |
|
|
2020
Q4 | $784K | Sell |
39,100
-15,500
| -28% | -$304K | ﹤0.01% | 1682 |
|
|
2020
Q3 | $935K | Sell |
54,600
-30,100
| -36% | -$569K | ﹤0.01% | 1529 |
|
|
2020
Q2 | $1.85M | Buy |
84,700
+43,400
| +105% | +$994K | 0.01% | 1244 |
|
|
2020
Q1 | $955K | Sell |
41,300
-700
| -2% | -$20.3K | ﹤0.01% | 1512 |
|
|
2019
Q4 | $1.39M | Buy |
42,000
+26,900
| +178% | +$862K | ﹤0.01% | 1407 |
|
|
2019
Q3 | $481K | Buy |
+15,100
| New | +$440K | ﹤0.01% | 1728 |
|
|
2016
Q4 | – | Sell |
-36,184
| Closed | -$1.42M | – | 2488 |
|
|
2016
Q3 | $1.42M | Buy |
36,184
+5,400
| +18% | +$215K | 0.01% | 1182 |
|
|
2016
Q2 | $1.16M | Buy |
30,784
+19,200
| +166% | +$643K | 0.01% | 1096 |
|
|
2016
Q1 | $445K | Buy |
11,584
+2,500
| +28% | +$93.1K | ﹤0.01% | 1508 |
|
|
2015
Q4 | $436K | Buy |
+9,084
| New | +$420K | ﹤0.01% | 1380 |
|
|
2015
Q3 | – | Sell |
-12,784
| Closed | -$544K | – | 2045 |
|
|
2015
Q2 | $544K | Buy |
+12,784
| New | +$509K | ﹤0.01% | 1394 |
|
|
2015
Q1 | – | Sell |
-21,084
| Closed | -$760K | – | 2486 |
|
|
2014
Q4 | $760K | Sell |
21,084
-4,016
| -16% | -$135K | 0.01% | 1331 |
|
|
2014
Q3 | $741K | Sell |
25,100
-95,584
| -79% | -$2.64M | 0.01% | 1311 |
|
|
2014
Q2 | $3.03M | Buy |
120,684
+62,100
| +106% | +$1.54M | 0.02% | 636 |
|
|
2014
Q1 | $1.51M | Sell |
58,584
-6,200
| -10% | -$156K | 0.01% | 906 |
|
|
2013
Q4 | $1.46M | Buy |
64,784
+39,100
| +152% | +$755K | 0.01% | 923 |
|
|
2013
Q3 | $365K | Sell |
25,684
-8,100
| -24% | -$108K | ﹤0.01% | 1582 |
|
|
2013
Q2 | $461K | Buy |
+33,784
| New | +$460K | 0.01% | 1386 |
|
Other funds holding NTUS
Two Sigma Advisers's NTUS Position: Q3 2022 in Review
Two Sigma Advisers sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 28,500 shares — an estimated $934K sold.
Two Sigma Advisers first reported a position in NTUS in Q2 2013 and held it in 24 quarters. The position peaked at $3.03M in Q2 2014. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Two Sigma Advisers reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Two Sigma Advisers sold 28,500 Natus Medical Inc shares in Q3 2022, an estimated $934K.
- Two Sigma Advisers first reported a position in Natus Medical Inc in Q2 2013 and held it in 24 quarters.
- Two Sigma Advisers's Natus Medical Inc position peaked at $3.03M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.